Macromolecular and Inorganic Nanomaterials Scaffolds for Carbon Monoxide Delivery: Recent Developments and Future Trends

ACS Biomaterials Science and Engineering

Volumn 1, Issue 10, 2015, Pages 895-913

  Nguyen, Diep ^a   Boyer, Cyrille ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

carbon monoxide (CO); CO releasing molecules (CORMs); inorganic hybrid scaffolds and drug delivery; macromolecular CORMs

Indexed keywords

AMPHOPHILE; CARBON MONOXIDE; DENDRIMER; DRUG CARRIER; MOLECULAR SCAFFOLD;

DONOR; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; HUMAN; HYBRID; MACROMOLECULE; MOLECULAR BIOLOGY; NANOENCAPSULATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW;

EID: 84991521458     PISSN: None     EISSN: 23739878     Source Type: Journal    
DOI: 10.1021/acsbiomaterials.5b00230     Document Type: Review

References (163)

1. Widdop, B. Analysis of carbon monoxide Ann. Clin. Biochem. 2002, 39, 378-391 10.1258/000456302760042146
2. Motterlini, R.; Otterbein, L. E. The therapeutic potential of carbon monoxide Nat. Rev. Drug Discovery 2010, 9, 728-743 10.1038/nrd3228
3. Mann, B. E.; Motterlini, R. CO and NO in medicine Chem. Commun. 2007, 43, 4197-4208 10.1039/b704873d
4. Stupfel, M.; Bouley, G. Physiological and Biochemical Effects on Rats and Mice Exposed to Small Concentrations of Carbon Monoxide for Long Periods Ann. N. Y. Acad. Sci. 1970, 174, 342-368 10.1111/j.1749-6632.1970.tb49799.x
5. Amersi, F.; Shen, X.-D.; Anselmo, D.; Melinek, J.; Iyer, S.; Southard, D. J.; Katori, M.; Volk, H.-D.; Busuttil, R. W.; Buelow, R.; Kupiec-Weglinski, J. W. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway Hepatology 2002, 35, 815-823
6. Günther, L.; Berberat, P. O.; Haga, M.; Brouard, S.; Smith, R. N.; Soares, M. P.; Bach, F. H.; Tobiasch, E. Carbon Monoxide Protects Pancreatic β-Cells From Apoptosis and Improves Islet Function/Survival After Transplantation Diabetes 2002, 51, 994-999 10.2337/diabetes.51.4.994
7. Ozawa, N.; Goda, N.; Makino, N.; Yamaguchi, T.; Yoshimura, Y.; Suematsu, M. Leydig cell-derived heme oxygenase-1 regulates apoptosis of premeiotic germ cells in response to stress J. Clin. Invest. 2002, 109, 457-467 10.1172/JCI0213190
8. Morse, D.; Sethi, J.; Choi, A. M. K. Carbon monoxide-dependent signaling Crit. Care Med. 2002, 30, S12-S17 10.1097/00003246-200201001-00002
9. Otterbein, L. E.; Mantell, L. L.; Choi, A. M. Carbon monoxide provides protection against hyperoxic lung injury Am. J. Physiol. 1999, 276, L688-694
10. Morita, T.; Mitsialis, S. A.; Koike, H.; Liu, Y.; Kourembanas, S. Carbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells J. Biol. Chem. 1997, 272, 32804-32809 10.1074/jbc.272.52.32804
11. Baranano, D. E.; Doré, S.; Ferris, C. D.; Snyder, S. H. Physiologic roles for the heme oxygenase products carbon monoxide, bilirubin and iron: links to neuroprotection in stroke and Alzheimer's disease Clin. Neurosci. Res. 2001, 1, 46-52 10.1016/S1566-2772(00)00006-2
12. Tschugguel, W.; Stonek, F.; Zhegu, Z.; Dietrich, W.; Schneeberger, C.; Stimpfl, T.; Waldhoer, T.; Vycudilik, W.; Huber, J. C. Estrogen Increases Endothelial Carbon Monoxide, Heme Oxygenase 2, and Carbon Monoxide-Derived cGMP by a Receptor-Mediated System J. Clin. Endocrinol. Metab. 2001, 86, 3833-3839 10.1210/jcem.86.8.7715
13. Seymour, L. W. Passive tumor targeting of soluble macromolecules and drug conjugates Crit. Rev. Ther. Drug Carrier Syst. 1992, 9, 135-187
14. Maeda, H.; Nakamura, H.; Fang, J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Adv. Drug Delivery Rev. 2013, 65, 71-79 10.1016/j.addr.2012.10.002
15. Nakamura, H.; Jun, F.; Maeda, H. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls Expert Opin. Drug Delivery 2015, 12, 53-64 10.1517/17425247.2014.955011
16. Torchilin, V. P. Multifunctional nanocarriers Adv. Drug Delivery Rev. 2012, 64, 302-315 10.1016/j.addr.2012.09.031
17. Maines, M. D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications FASEB J. 1988, 2, 2557-2568
18. Stone, J. R.; Marletta, M. A. Soluble Guanylate Cyclase from Bovine Lung: Activation with Nitric Oxide and Carbon Monoxide and Spectral Characterization of the Ferrous and Ferric States Biochemistry 1994, 33, 5636-5640 10.1021/bi00184a036
19. Brune, B.; Ullrich, V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase Mol. Pharmacol. 1987, 32, 497-504
20. Hoshi, T.; Pantazis, A.; Olcese, R. Transduction of Voltage and Ca2+ Signals by Slo1 BK Channels Physiology 2013, 28, 172-189 10.1152/physiol.00055.2012
21. Patterson, A. J.; Henrie-Olson, J.; Brenner, R. Vasoregulation at the Molecular Level: A Role for the β1 Subunit of the Calcium-Activated Potassium (BK) Channel Trends Cardiovasc. Med. 2002, 12, 78-82 10.1016/S1050-1738(01)00146-3
22. Nelson, M. T.; Quayle, J. M. Physiological roles and properties of potassium channels in arterial smooth muscle Am. J. Physiol. 1995, 268, 799-822
23. Brenner, R.; Perez, G. J.; Bonev, A. D.; Eckman, D. M.; Kosek, J. C.; Wiler, S. W.; Patterson, A. J.; Nelson, M. T.; Aldrich, R. W. Vasoregulation by the [beta]1 subunit of the calcium-activated potassium channel Nature 2000, 407, 870-876 10.1038/35038011
24. Scragg, J. L.; Dallas, M. L.; Wilkinson, J. A.; Varadi, G.; Peers, C. Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species J. Biol. Chem. 2008, 283, 24412-24419 10.1074/jbc.M803037200
25. Taille, C.; El-Benna, J.; Lanone, S.; Boczkowski, J.; Motterlini, R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle J. Biol. Chem. 2005, 280, 25350-25360 10.1074/jbc.M503512200
26. Sawle, P.; Foresti, R.; Mann, B. E.; Johnson, T. R.; Green, C. J.; Motterlini, R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages Br. J. Pharmacol. 2005, 145, 800-810 10.1038/sj.bjp.0706241
27. Srisook, K.; Han, S.-S.; Choi, H.-S.; Li, M.-H.; Ueda, H.; Kim, C.; Cha, Y.-N. CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages Biochem. Pharmacol. 2006, 71, 307-318 10.1016/j.bcp.2005.10.042
28. Coceani, F.; Kelsey, L.; Seidlitz, E. Carbon monoxide-induced relaxation of the ductus arteriosus in the lamb: evidence against the prime role of guanylyl cyclase Br. J. Pharmacol. 1996, 118, 1689-1696 10.1111/j.1476-5381.1996.tb15593.x
29. Otterbein, L. E.; Bach, F. H.; Alam, J.; Soares, M.; Lu, H. T.; Wysk, M.; Davis, R. J.; Flavell, R. A.; Choi, A. M. K. Carbon monoxide has anti-inflammatory effects involving the mitogen- activated protein kinase pathway Nat. Med. 2000, 6, 422-428 10.1038/74680
30. Morse, D.; Pischke, S. E.; Zhou, Z.; Davis, R. J.; Flavell, R. A.; Loop, T.; Otterbein, S. L.; Otterbein, L. E.; Choi, A. M. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1 J. Biol. Chem. 2003, 278, 36993-36998 10.1074/jbc.M302942200
31. Pamplona, A.; Ferreira, A.; Balla, J.; Jeney, V.; Balla, G.; Epiphanio, S.; Chora, A.; Rodrigues, C. D.; Gregoire, I. P.; Cunha-Rodrigues, M.; Portugal, S.; Soares, M. P.; Mota, M. M. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria Nat. Med. 2007, 13, 703-710 10.1038/nm1586
32. Bathoorn, E.; Slebos, D. J.; Postma, D. S.; Koeter, G. H.; van Oosterhout, A. J.; van der Toorn, M.; Boezen, H. M.; Kerstjens, H. A. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Eur. Respir. J. 2007, 30, 1131-1137 10.1183/09031936.00163206
33. Durante, W. Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Med. 2002, 7, 195-202 10.1191/1358863x02vm424ra
34. Zuckerbraun, B. S.; Chin, B. Y.; Wegiel, B.; Billiar, T. R.; Czsimadia, E.; Rao, J.; Shimoda, L.; Ifedigbo, E.; Kanno, S.; Otterbein, L. E. Carbon monoxide reverses established pulmonary hypertension J. Exp. Med. 2006, 203, 2109-2119 10.1084/jem.20052267
35. Motterlini, R.; Clark, J. E.; Foresti, R.; Sarathchandra, P.; Mann, B. E.; Green, C. J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities Circ. Res. 2002, 90, E17-24 10.1161/hh0202.104530
36. Yoshida, J.; Ozaki, K. S.; Nalesnik, M. A.; Ueki, S.; Castillo-Rama, M.; Faleo, G.; Ezzelarab, M.; Nakao, A.; Ekser, B.; Echeverri, G. J.; Ross, M. A.; Stolz, D. B.; Murase, N. Ex vivo Application of Carbon Monoxide in UW Solution Prevents Transplant-Induced Renal Ischemia/Reperfusion Injury in Pigs Am. J. Transplant. 2010, 10, 763-772 10.1111/j.1600-6143.2010.03040.x
37. Takahashi, T.; Morita, K.; Akagi, R.; Sassa, S. Protective Role of Heme Oxygenase-1 in Renal Ischemia Antioxid. Redox Signaling 2004, 6, 867-877 10.1089/1523086041798123
38. Tamura, Y.; Imaoka, S.; Gemba, M.; Funae, Y. Effects of ischemia-reperfusion on individual cytochrome P450 isoforms in the rat kidney Life Sci. 1996, 60, 143-149 10.1016/S0024-3205(96)00604-2
39. Paller, M. S.; Jacob, H. S. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 7002-7006 10.1073/pnas.91.15.7002
40. Nakao, A.; Faleo, G.; Shimizu, H.; Nakahira, K.; Kohmoto, J.; Sugimoto, R.; Choi, A. M. K.; McCurry, K. R.; Takahashi, T.; Murase, N. Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia//reperfusion injury of kidney grafts Kidney Int. 2008, 74, 1009-1016 10.1038/ki.2008.342
41. Dixon, S. J.; Stockwell, B. R. The role of iron and reactive oxygen species in cell death Nat. Chem. Biol. 2014, 10, 9-17 10.1038/nchembio.1416
42. Vincent, J.-L. Nosocomial infections in adult intensive-care units Lancet 2003, 361, 2068-2077 10.1016/S0140-6736(03)13644-6
43. Andersson, D. I.; Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 2010, 8, 260-271 10.1038/nrmicro2319
44. Nobre, L. S.; Seixas, J. D.; Romao, C. C.; Saraiva, L. M. Antimicrobial action of carbon monoxide-releasing compounds Antimicrob. Agents Chemother. 2007, 51, 4303-4307 10.1128/AAC.00802-07
45. Desmard, M.; Foresti, R.; Morin, D.; Dagouassat, M.; Berdeaux, A.; Denamur, E.; Crook, S. H.; Mann, B. E.; Scapens, D.; Montravers, P.; Boczkowski, J.; Motterlini, R. Differential Antibacterial Activity Against Pseudomonas aeruginosa by Carbon Monoxide-Releasing Molecules Antioxid. Redox Signaling 2011, 16, 153-163 10.1089/ars.2011.3959
46. Wilson, J. L.; Jesse, H. E.; Hughes, B.; Lund, V.; Naylor, K.; Davidge, K. S.; Cook, G. M.; Mann, B. E.; Poole, R. K. Ru(CO)3Cl(Glycinate) (CORM-3): a carbon monoxide-releasing molecule with broad-spectrum antimicrobial and photosensitive activities against respiration and cation transport in Escherichia coli Antioxid. Redox Signaling 2013, 19, 497-509 10.1089/ars.2012.4784
47. Wegiel, B.; Larsen, R.; Gallo, D.; Chin, B. Y.; Harris, C.; Mannam, P.; Kaczmarek, E.; Lee, P. J.; Zuckerbraun, B. S.; Flavell, R.; Soares, M. P.; Otterbein, L. E. Macrophages sense and kill bacteria through carbon monoxide-dependent inflammasome activation J. Clin. Invest. 2014, 124, 4926-4940 10.1172/JCI72853
48. Otterbein, L. E.; May, A.; Chin, B. Y. Carbon monoxide increases macrophage bacterial clearance through Toll-like receptor (TLR)4 expression Cell. Mol. Biol. 2005, 51, 433-440
49. Chung, S. W.; Liu, X.; Macias, A. A.; Baron, R. M.; Perrella, M. A. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice J. Clin. Invest. 2008, 118, 239-247 10.1172/JCI32730
50. Heinemann, S. H.; Hoshi, T.; Westerhausen, M.; Schiller, A. Carbon monoxide-physiology, detection and controlled release Chem. Commun. 2014, 50, 3644-3660 10.1039/c3cc49196j
51. Davidge, K. S.; Motterlini, R.; Mann, B. E.; Wilson, J. L.; Poole, R. K. In Advances in Microbial Physiology; Robert, K. P., Ed.; Academic Press: New York, 2009; Vol. 56, pp 85-167.
52. Romao, C. C.; Blattler, W. A.; Seixas, J. D.; Bernardes, G. J. L. Developing drug molecules for therapy with carbon monoxide Chem. Soc. Rev. 2012, 41, 3571-3583 10.1039/c2cs15317c
53. Mann, B. E. CO-Releasing Molecules: A Personal View Organometallics 2012, 31, 5728-5735 10.1021/om300364a
54. Alberto, R.; Motterlini, R. Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes Dalton Trans. 2007, 36, 1651-1660 10.1039/b701992k
55. García-Gallego, S.; Bernardes, G. J. L. Carbon-Monoxide-Releasing Molecules for the Delivery of Therapeutic CO In Vivo Angew. Chem., Int. Ed. 2014, 53, 9712-9721 10.1002/anie.201311225
56. Zobi, F. CO and CO-releasing molecules in medicinal chemistry Future Med. Chem. 2013, 5, 175-188 10.4155/fmc.12.196
57. Gasser, G.; Metzler-Nolte, N. The potential of organometallic complexes in medicinal chemistry Curr. Opin. Chem. Biol. 2012, 16, 84-91 10.1016/j.cbpa.2012.01.013
58. Pena, A. C.; Penacho, N.; Mancio-Silva, L.; Neres, R.; Seixas, J. D.; Fernandes, A. C.; Romao, C. C.; Mota, M. M.; Bernardes, G. J.; Pamplona, A. A novel carbon monoxide-releasing molecule fully protects mice from severe malaria Antimicrob. Agents Chemother. 2012, 56, 1281-1290 10.1128/AAC.05571-11
59. Schatzschneider, U. Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs) Br. J. Pharmacol. 2015, 172, 1638-1650 10.1111/bph.12688
60. Johnson, T. R.; Mann, B. E.; Teasdale, I. P.; Adams, H.; Foresti, R.; Green, C. J.; Motterlini, R. Metal carbonyls as pharmaceuticals? [Ru(CO)3Cl(glycinate)], a CO-releasing molecule with an extensive aqueous solution chemistry Dalton Trans. 2007, 36, 1500-1508 10.1039/b613629j
61. Clark, J. E.; Naughton, P.; Shurey, S.; Green, C. J.; Johnson, T. R.; Mann, B. E.; Foresti, R.; Motterlini, R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule Circ. Res. 2003, 93, e2-8
62. Desmard, M.; Davidge, K. S.; Bouvet, O.; Morin, D.; Roux, D.; Foresti, R.; Ricard, J. D.; Denamur, E.; Poole, R. K.; Montravers, P.; Motterlini, R.; Boczkowski, J. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia FASEB J. 2009, 23, 1023-1031 10.1096/fj.08-122804
63. Foresti, R.; Hammad, J.; Clark, J. E.; Johnson, T. R.; Mann, B. E.; Friebe, A.; Green, C. J.; Motterlini, R. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule Br. J. Pharmacol. 2004, 142, 453-460 10.1038/sj.bjp.0705825
64. Schatzschneider, U. PhotoCORMs: Light-triggered release of carbon monoxide from the coordination sphere of transition metal complexes for biological applications Inorg. Chim. Acta 2011, 374, 19-23 10.1016/j.ica.2011.02.068
65. Niesel, J.; Pinto, A.; N'Dongo, H. W. P.; Merz, K.; Ott, I.; Gust, R.; Schatzschneider, U. Photoinduced CO release, cellular uptake and cytotoxicity of a tris(pyrazolyl)methane (tpm) manganese tricarbonyl complex Chem. Commun. 2008, 1798-1800 10.1039/b719075a
66. Meister, K.; Niesel, J.; Schatzschneider, U.; Metzler-Nolte, N.; Schmidt, D. A.; Havenith, M. Label-Free Imaging of Metal-Carbonyl Complexes in Live Cells by Raman Microspectroscopy Angew. Chem., Int. Ed. 2010, 49, 3310-3312 10.1002/anie.201000097
67. Pfeiffer, H.; Rojas, A.; Niesel, J.; Schatzschneider, U. Sonogashira and ″Click″ reactions for the N-terminal and side-chain functionalization of peptides with [Mn(CO)3(tpm)]+-based CO releasing molecules (tpm = tris(pyrazolyl)methane) Dalton Trans. 2009, 38, 4292-4298 10.1039/b819091g
68. Kunz, P. C.; Huber, W.; Rojas, A.; Schatzschneider, U.; Spingler, B. Tricarbonylmanganese(I) and-rhenium(I) Complexes of Imidazol-Based Phosphane Ligands: Influence of the Substitution Pattern on the CO Release Properties Eur. J. Inorg. Chem. 2009, 2009, 5358-5366 10.1002/ejic.200900650
69. Nagel, C.; McLean, S.; Poole, R. K.; Braunschweig, H.; Kramer, T.; Schatzschneider, U. Introducing [Mn(CO)3(tpa-[small kappa]3N)]+ as a novel photoactivatable CO-releasing molecule with well-defined iCORM intermediates-synthesis, spectroscopy, and antibacterial activity Dalton Trans. 2014, 43, 9986-9997 10.1039/c3dt51848e
70. Rimmer, R. D.; Richter, H.; Ford, P. C. A Photochemical Precursor for Carbon Monoxide Release in Aerated Aqueous Media Inorg. Chem. 2010, 49, 1180-1185 10.1021/ic902147n
71. Rimmer, R. D.; Pierri, A. E.; Ford, P. C. Photochemically activated carbon monoxide release for biological targets. Toward developing air-stable photoCORMs labilized by visible light Coord. Chem. Rev. 2012, 256, 1509-1519 10.1016/j.ccr.2011.12.009
72. Gonzales, M. A.; Mascharak, P. K. Photoactive metal carbonyl complexes as potential agents for targeted CO delivery J. Inorg. Biochem. 2014, 133, 127-135 10.1016/j.jinorgbio.2013.10.015
73. Szaciowski, K.; Macyk, W.; Drzewiecka-Matuszek, A.; Brindell, M.; Stochel, G. Bioinorganic Photochemistry: Frontiers and Mechanisms Chem. Rev. 2005, 105, 2647-2694 10.1021/cr030707e
74. Farrer, N. J.; Salassa, L.; Sadler, P. J. Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine Dalton Trans. 2009, 38, 10690-10701 10.1039/b917753a
75. Pierri, A. E.; Pallaoro, A.; Wu, G.; Ford, P. C. A Luminescent and Biocompatible PhotoCORM J. Am. Chem. Soc. 2012, 134, 18197-18200 10.1021/ja3084434
76. Marques, A. R.; Kromer, L.; Gallo, D. J.; Penacho, N.; Rodrigues, S. S.; Seixas, J. D.; Bernardes, G. J. L.; Reis, P. M.; Otterbein, S. L.; Ruggieri, R. A.; Gonçalves, A. S. G.; Gonçalves, A. M. L.; Matos, M. N. D.; Bento, I.; Otterbein, L. E.; Blättler, W. A.; Romao, C. C. Generation of Carbon Monoxide Releasing Molecules (CO-RMs) as Drug Candidates for the Treatment of Acute Liver Injury: Targeting of CO-RMs to the Liver Organometallics 2012, 31, 5810-5822 10.1021/om300360c
77. Zobi, F.; Quaroni, L.; Santoro, G.; Zlateva, T.; Blacque, O.; Sarafimov, B.; Schaub, M. C.; Bogdanova, A. Y. Live-fibroblast IR imaging of a cytoprotective PhotoCORM Activated with Visible Light J. Med. Chem. 2013, 56, 6719-6731 10.1021/jm400527k
78. McLean, S.; Mann, B. E.; Poole, R. K. Sulfite species enhance carbon monoxide release from CO-releasing molecules: Implications for the deoxymyoglobin assay of activity Anal. Biochem. 2012, 427, 36-40 10.1016/j.ab.2012.04.026
79. Atkin, A. J.; Lynam, J. M.; Moulton, B. E.; Sawle, P.; Motterlini, R.; Boyle, N. M.; Pryce, M. T.; Fairlamb, I. J. S. Modification of the deoxy-myoglobin/carbonmonoxy-myoglobin UV-vis assay for reliable determination of CO-release rates from organometallic carbonyl complexes Dalton Trans. 2011, 40, 5755-5761 10.1039/c0dt01809k
80. Crook, S. H.; Mann, B. E.; Meijer, A. J. H. M.; Adams, H.; Sawle, P.; Scapens, D.; Motterlini, R. [Mn(CO)4{S2CNMe(CH2CO2H)}], a new water-soluble CO-releasing molecule Dalton Trans. 2011, 40, 4230-4235 10.1039/c1dt10125k
81. Pitchumony, T. S.; Spingler, B.; Motterlini, R.; Alberto, R. Syntheses, structural characterization and CO releasing properties of boranocarbonate [H3BCO2H]- derivatives Org. Biomol. Chem. 2010, 8, 4849-4854 10.1039/c0ob00099j
82. Santos-Silva, T.; Mukhopadhyay, A.; Seixas, J. D.; Bernardes, G. J. L.; Romao, C. C.; Romao, M. J. CORM-3 Reactivity toward Proteins: The Crystal Structure of a Ru(II) Dicarbonyl-Lysozyme Complex J. Am. Chem. Soc. 2011, 133, 1192-1195 10.1021/ja108820s
83. Rimmer, R. D.; Richter, H.; Ford, P. C. A Photochemical Precursor for Carbon Monoxide Release in Aerated Aqueous Media Inorg. Chem. 2010, 49, 1180-1185 10.1021/ic902147n
84. Obirai, J. C.; Hamadi, S.; Ithurbide, A.; Wartelle, C.; Nyokong, T.; Zagal, J.; Top, S.; Bedioui, F. UV-Visible and Electrochemical Monitoring of Carbon Monoxide Release by Donor Complexes to Myoglobin Solutions and to Electrodes Modified with Films Containing Hemin Electroanalysis 2006, 18, 1689-1695 10.1002/elan.200603571
85. Esteban, J.; Ros-Lis, J. V.; Martínez-Mánez, R.; Marcos, M. D.; Moragues, M.; Soto, J.; Sancenón, F. Sensitive and Selective Chromogenic Sensing of Carbon Monoxide by Using Binuclear Rhodium Complexes Angew. Chem., Int. Ed. 2010, 49, 4934-4937 10.1002/anie.201001344
86. Moragues, M. E.; Esteban, J.; Ros-Lis, J. V.; Martínez-Mánez, R.; Marcos, M. D.; Martínez, M.; Soto, J.; Sancenón, F. Sensitive and Selective Chromogenic Sensing of Carbon Monoxide via Reversible Axial CO Coordination in Binuclear Rhodium Complexes J. Am. Chem. Soc. 2011, 133, 15762-15772 10.1021/ja206251r
87. Yuan, L.; Lin, W.; Tan, L.; Zheng, K.; Huang, W. Lighting up Carbon Monoxide: Fluorescent Probes for Monitoring CO in Living Cells Angew. Chem., Int. Ed. 2013, 52, 1628-1630 10.1002/anie.201208346
88. Michel, B. W.; Lippert, A. R.; Chang, C. J. A Reaction-Based Fluorescent Probe for Selective Imaging of Carbon Monoxide in Living Cells Using a Palladium-Mediated Carbonylation J. Am. Chem. Soc. 2012, 134, 15668-15671 10.1021/ja307017b
89. Wu, L.; Wang, R. Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev. 2005, 57, 585-630 10.1124/pr.57.4.3
90. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46, 6387-6392
91. Maeda, H.; Matsumura, Y. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy Adv. Drug Delivery Rev. 2011, 63, 129-130 10.1016/j.addr.2010.05.001
92. Maeda, H. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects Bioconjugate Chem. 2010, 21, 797-802 10.1021/bc100070g
93. Yezhelyev, M. V.; Gao, X.; Xing, Y.; Al-Hajj, A.; Nie, S.; O'Regan, R. M. Emerging use of nanoparticles in diagnosis and treatment of breast cancer Lancet Oncol. 2006, 7, 657-667 10.1016/S1470-2045(06)70793-8
94. Kunz, P. C.; Brückmann, N. E.; Spingler, B. Towards Polymer Diagnostic Agents Copolymers of N-(2-Hydroxypropyl)methacrylamide and Bis(2-pyridylmethyl)-4-vinylbenzylamine: Synthesis, Characterisation and Re(CO)3-Labelling Eur. J. Inorg. Chem. 2007, 2007, 394-399 10.1002/ejic.200600824
95. Brückmann, N. E.; Wahl, M.; Reiß, G. J.; Kohns, M.; Wätjen, W.; Kunz, P. C. Polymer Conjugates of Photoinducible CO-Releasing Molecules Eur. J. Inorg. Chem. 2011, 2011, 4571-4577 10.1002/ejic.201100545
96. Hasegawa, U.; van der Vlies, A. J.; Simeoni, E.; Wandrey, C.; Hubbell, J. A. Carbon Monoxide-Releasing Micelles for Immunotherapy J. Am. Chem. Soc. 2010, 132, 18273-18280 10.1021/ja1075025
97. Yin, H.; Fang, J.; Liao, L.; Nakamura, H.; Maeda, H. Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease J. Controlled Release 2014, 187, 14-21 10.1016/j.jconrel.2014.05.018
98. Pierri, A. E.; Huang, P.-J.; Garcia, J. V.; Stanfill, J. G.; Chui, M.; Wu, G.; Zheng, N.; Ford, P. C. A photoCORM nanocarrier for CO release using NIR light Chem. Commun. 2015, 51, 2072-2075 10.1039/C4CC06766E
99. Dördelmann, G.; Pfeiffer, H.; Birkner, A.; Schatzschneider, U. Silicium Dioxide Nanoparticles As Carriers for Photoactivatable CO-Releasing Molecules (PhotoCORMs) Inorg. Chem. 2011, 50, 4362-4367 10.1021/ic1024197
100. Gonzales, M. A.; Han, H.; Moyes, A.; Radinos, A.; Hobbs, A. J.; Coombs, N.; Oliver, S. R. J.; Mascharak, P. K. Light-triggered carbon monoxide delivery with Al-MCM-41-based nanoparticles bearing a designed manganese carbonyl complex J. Mater. Chem. B 2014, 2, 2107-2113 10.1039/c3tb21309a
101. Dordelmann, G.; Meinhardt, T.; Sowik, T.; Krueger, A.; Schatzschneider, U. CuAAC click functionalization of azide-modified nanodiamond with a photoactivatable CO-releasing molecule (PhotoCORM) based on [Mn(CO)3(tpm)]+ Chem. Commun. 2012, 48, 11528-11530 10.1039/c2cc36491c
102. Kunz, P. C.; Meyer, H.; Barthel, J.; Sollazzo, S.; Schmidt, A. M.; Janiak, C. Metal carbonyls supported on iron oxide nanoparticles to trigger the CO-gasotransmitter release by magnetic heating Chem. Commun. 2013, 49, 4896-4898 10.1039/c3cc41411f
103. Ma, M.; Noei, H.; Mienert, B.; Niesel, J.; Bill, E.; Muhler, M.; Fischer, R. A.; Wang, Y.; Schatzschneider, U.; Metzler-Nolte, N. Iron Metal-Organic Frameworks MIL-88B and NH2-MIL-88B for the Loading and Delivery of the Gasotransmitter Carbon Monoxide Chem.-Eur. J. 2013, 19, 6785-6790 10.1002/chem.201201743
104. Matson, J. B.; Webber, M. J.; Tamboli, V. K.; Weber, B.; Stupp, S. I. A peptide-based material for therapeutic carbon monoxide delivery Soft Matter 2012, 8, 6689-6692 10.1039/c2sm25785h
105. Tabe, H.; Fujita, K.; Abe, S.; Tsujimoto, M.; Kuchimaru, T.; Kizaka-Kondoh, S.; Takano, M.; Kitagawa, S.; Ueno, T. Preparation of a Cross-Linked Porous Protein Crystal Containing Ru Carbonyl Complexes as a CO-Releasing Extracellular Scaffold Inorg. Chem. 2015, 54, 215-220 10.1021/ic502159x
106. Govender, P.; Pai, S.; Schatzschneider, U.; Smith, G. S. Next Generation PhotoCORMs: Polynuclear Tricarbonylmanganese(I)-Functionalized Polypyridyl Metallodendrimers Inorg. Chem. 2013, 52, 5470-5478 10.1021/ic400377k
107. Pillai, O.; Panchagnula, R. Polymers in drug delivery Curr. Opin. Chem. Biol. 2001, 5, 447-451 10.1016/S1367-5931(00)00227-1
108. Santos-Magalhaes, N. S.; Mosqueira, V. C. F. Nanotechnology applied to the treatment of malaria Adv. Drug Delivery Rev. 2010, 62, 560-575 10.1016/j.addr.2009.11.024
109. Kopeček, J.; Kopečková, P.; Minko, T.; Lu, Z.-R. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action Eur. J. Pharm. Biopharm. 2000, 50, 61-81 10.1016/S0939-6411(00)00075-8
110. Talelli, M.; Rijcken, C. J. F.; van Nostrum, C. F.; Storm, G.; Hennink, W. E. Micelles based on HPMA copolymers Adv. Drug Delivery Rev. 2010, 62, 231-239 10.1016/j.addr.2009.11.029
111. Mitra, A.; Nan, A.; Ghandehari, H.; McNeil, E.; Mulholland, J.; Line, B. Technetium-99m-Labeled N-(2-Hydroxypropyl) Methacrylamide Copolymers: Synthesis, Characterization, and in Vivo Biodistribution Pharm. Res. 2004, 21, 1153-1159 10.1023/B:PHAM.0000033001.49737.b7
112. Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C.-W.; Lin, V. S. Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Delivery Rev. 2008, 60, 1278-1288 10.1016/j.addr.2008.03.012
113. Rosenholm, J. M.; Sahlgren, C.; Linden, M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-opportunities & challenges Nanoscale 2010, 2, 1870-1883 10.1039/c0nr00156b
114. Mamaeva, V.; Sahlgren, C.; Lindén, M. Mesoporous silica nanoparticles in medicine-Recent advances Adv. Drug Delivery Rev. 2013, 65, 689-702 10.1016/j.addr.2012.07.018
115. Ambrogio, M. W.; Thomas, C. R.; Zhao, Y.-L.; Zink, J. I.; Stoddart, J. F. Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 903-913 10.1021/ar200018x
116. Benezra, M.; Penate-Medina, O.; Zanzonico, P. B.; Schaer, D.; Ow, H.; Burns, A.; DeStanchina, E.; Longo, V.; Herz, E.; Iyer, S.; Wolchok, J.; Larson, S. M.; Wiesner, U.; Bradbury, M. S. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma J. Clin. Invest. 2011, 121, 2768-2780 10.1172/JCI45600
117. Wang, X.; Low, X. C.; Hou, W.; Abdullah, L. N.; Toh, T. B.; Mohd Abdul Rashid, M.; Ho, D.; Chow, E. K.-H. Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells ACS Nano 2014, 8, 12151-12166 10.1021/nn503491e
118. Mochalin, V. N.; Pentecost, A.; Li, X.-M.; Neitzel, I.; Nelson, M.; Wei, C.; He, T.; Guo, F.; Gogotsi, Y. Adsorption of Drugs on Nanodiamond: Toward Development of a Drug Delivery Platform Mol. Pharmaceutics 2013, 10, 3728-3735 10.1021/mp400213z
119. Toh, T.-B.; Lee, D.-K.; Hou, W.; Abdullah, L. N.; Nguyen, J.; Ho, D.; Chow, E. K.-H. Nanodiamond-Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells Mol. Pharmaceutics 2014, 11, 2683-2691 10.1021/mp5001108
120. Chow, E. K.; Zhang, X. Q.; Chen, M.; Lam, R.; Robinson, E.; Huang, H.; Schaffer, D.; Osawa, E.; Goga, A.; Ho, D. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment Sci. Transl. Med. 2011, 3, 73ra21 10.1126/scitranslmed.3001713
121. Kuang-Kai, L.; Wen-Wei, Z.; Chi-Ching, W.; Yu-Chung, C.; Chia-Liang, C.; Yu-Shiu, L.; Chinpiao, C.; Jui, I. C. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy Nanotechnology 2010, 21, 315106 10.1088/0957-4484/21/31/315106
122. Man, H. B.; Kim, H.; Kim, H.-J.; Robinson, E.; Liu, W. K.; Chow, E. K.-H.; Ho, D. Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia Nanomedicine 2014, 10, 359-369 10.1016/j.nano.2013.07.014
123. Sundaresan, V.; Menon, J. U.; Rahimi, M.; Nguyen, K. T.; Wadajkar, A. S. Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications Int. J. Pharm. 2014, 466, 1-7 10.1016/j.ijpharm.2014.03.016
124. Quan, Q.; Xie, J.; Gao, H.; Yang, M.; Zhang, F.; Liu, G.; Lin, X.; Wang, A.; Eden, H. S.; Lee, S.; Zhang, G.; Chen, X. HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy Mol. Pharmaceutics 2011, 8, 1669-1676 10.1021/mp200006f
125. Arruebo, M.; Fernández-Pacheco, R.; Ibarra, M. R.; Santamaría, J. Magnetic nanoparticles for drug delivery Nano Today 2007, 2, 22-32 10.1016/S1748-0132(07)70084-1
126. Pouponneau, P.; Leroux, J.-C.; Soulez, G.; Gaboury, L.; Martel, S. Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation Biomaterials 2011, 32, 3481-3486 10.1016/j.biomaterials.2010.12.059
127. Kumar, M.; Yigit, M.; Dai, G.; Moore, A.; Medarova, Z. Image-guided breast tumor therapy using a small interfering RNA nanodrug Cancer Res. 2010, 70, 7553-7561 10.1158/0008-5472.CAN-10-2070
128. Cook, T. R.; Zheng, Y.-R.; Stang, P. J. Metal-Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal-Organic Materials Chem. Rev. 2013, 113, 734-777 10.1021/cr3002824
129. Xiao, B.; Wheatley, P. S.; Zhao, X.; Fletcher, A. J.; Fox, S.; Rossi, A. G.; Megson, I. L.; Bordiga, S.; Regli, L.; Thomas, K. M.; Morris, R. E. High-Capacity Hydrogen and Nitric Oxide Adsorption and Storage in a Metal-Organic Framework J. Am. Chem. Soc. 2007, 129, 1203-1209 10.1021/ja066098k
130. Hinks, N. J.; McKinlay, A. C.; Xiao, B.; Wheatley, P. S.; Morris, R. E. Metal organic frameworks as NO delivery materials for biological applications Microporous Mesoporous Mater. 2010, 129, 330-334 10.1016/j.micromeso.2009.04.031
131. Ingleson, M. J.; Heck, R.; Gould, J. A.; Rosseinsky, M. J. Nitric Oxide Chemisorption in a Postsynthetically Modified Metal-Organic Framework Inorg. Chem. 2009, 48, 9986-9988 10.1021/ic9015977
132. McKinlay, A. C.; Morris, R. E.; Horcajada, P.; Férey, G.; Gref, R.; Couvreur, P.; Serre, C. BioMOFs: Metal-Organic Frameworks for Biological and Medical Applications Angew. Chem., Int. Ed. 2010, 49, 6260-6266 10.1002/anie.201000048
133. Miller, S. R.; Heurtaux, D.; Baati, T.; Horcajada, P.; Greneche, J.-M.; Serre, C. Biodegradable therapeutic MOFs for the delivery of bioactive molecules Chem. Commun. 2010, 46, 4526-4528 10.1039/c001181a
134. Horcajada, P.; Gref, R.; Baati, T.; Allan, P. K.; Maurin, G.; Couvreur, P.; Férey, G.; Morris, R. E.; Serre, C. Metal-Organic Frameworks in Biomedicine Chem. Rev. 2012, 112, 1232-1268 10.1021/cr200256v
135. Dehsorkhi, A.; Castelletto, V.; Hamley, I. W. Self-assembling amphiphilic peptides J. Pept. Sci. 2014, 20, 453-467 10.1002/psc.2633
136. Cavalli, S.; Robson Marsden, H.; Albericio, F.; Kros, A. In Supramolecular Chemistry; John Wiley & Sons: New York, 2012.
137. Ravichandran, R.; Griffith, M.; Phopase, J. Applications of self-assembling peptide scaffolds in regenerative medicine: the way to the clinic J. Mater. Chem. B 2014, 2, 8466-8478 10.1039/C4TB01095G
138. Matson, J. B.; Stupp, S. I. Self-assembling peptide scaffolds for regenerative medicine Chem. Commun. 2012, 48, 26-33 10.1039/C1CC15551B
139. Maude, S.; Ingham, E.; Aggeli, A. Biomimetic self-assembling peptides as scaffolds for soft tissue engineering Nanomedicine 2013, 8, 823-847 10.2217/nnm.13.65
140. Wang, X.; Horii, A.; Zhang, S. Designer functionalized self-assembling peptide nanofiber scaffolds for growth, migration, and tubulogenesis of human umbilical vein endothelial cells Soft Matter 2008, 4, 2388-2395 10.1039/b807155a
141. Elzoghby, A. O.; Samy, W. M.; Elgindy, N. A. Albumin-based nanoparticles as potential controlled release drug delivery systems J. Controlled Release 2012, 157, 168-182 10.1016/j.jconrel.2011.07.031
142. Chen, L.; Remondetto, G. E.; Subirade, M. Food protein-based materials as nutraceutical delivery systems Trends Food Sci. Technol. 2006, 17, 272-283 10.1016/j.tifs.2005.12.011
143. Elzoghby, A. O.; Samy, W. M.; Elgindy, N. A. Protein-based nanocarriers as promising drug and gene delivery systems J. Controlled Release 2012, 161, 38-49 10.1016/j.jconrel.2012.04.036
144. Gunasekaran, S.; Ko, S.; Xiao, L. Use of whey proteins for encapsulation and controlled delivery applications J. Food Eng. 2007, 83, 31-40 10.1016/j.jfoodeng.2006.11.001
145. Razavet, M.; Artero, V.; Cavazza, C.; Oudart, Y.; Lebrun, C.; Fontecilla-Camps, J. C.; Fontecave, M. Tricarbonylmanganese(i)-lysozyme complex: a structurally characterized organometallic protein Chem. Commun. 2007, 43, 2805-2807 10.1039/b703887a
146. Casalot, L.; Rousset, M. Maturation of the [NiFe] hydrogenases Trends Microbiol. 2001, 9, 228-237 10.1016/S0966-842X(01)02009-1
147. Santos, M. F. A.; Seixas, J. D.; Coelho, A. C.; Mukhopadhyay, A.; Reis, P. M.; Romao, M. J.; Romao, C. C.; Santos-Silva, T. New insights into the chemistry of fac-[Ru(CO)3]2 + fragments in biologically relevant conditions: The CO releasing activity of [Ru(CO)3Cl2(1,3-thiazole)], and the X-ray crystal structure of its adduct with lysozyme J. Inorg. Biochem. 2012, 117, 285-291 10.1016/j.jinorgbio.2012.06.018
148. Zobi, F.; Spingler, B. Post-Protein-Binding Reactivity and Modifications of the fac-[Re(CO)3]+ Core Inorg. Chem. 2012, 51, 1210-1212 10.1021/ic2023314
149. Seixas, J. D.; Mukhopadhyay, A.; Santos-Silva, T.; Otterbein, L. E.; Gallo, D. J.; Rodrigues, S. S.; Guerreiro, B. H.; Goncalves, A. M. L.; Penacho, N.; Marques, A. R.; Coelho, A. C.; Reis, P. M.; Romao, M. J.; Romao, C. C. Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics Dalton Trans. 2013, 42, 5985-5998 10.1039/C2DT32174B
150. Crespo, L.; Sanclimens, G.; Pons, M.; Giralt, E.; Royo, M.; Albericio, F. Peptide and Amide Bond-Containing Dendrimers Chem. Rev. 2005, 105, 1663-1682 10.1021/cr030449l
151. Caminade, A.-M.; Turrin, C.-O. Dendrimers for drug delivery J. Mater. Chem. B 2014, 2, 4055-4066 10.1039/c4tb00171k
152. Kesharwani, P.; Jain, K.; Jain, N. K. Dendrimer as nanocarrier for drug delivery Prog. Polym. Sci. 2014, 39, 268-307 10.1016/j.progpolymsci.2013.07.005
153. Govender, P.; Therrien, B.; Smith, G. S. Bio-Metallodendrimers-Emerging Strategies in Metal-Based Drug Design Eur. J. Inorg. Chem. 2012, 2012, 2853-2862 10.1002/ejic.201200161
154. Chen, L.-J.; Zhao, G.-Z.; Jiang, B.; Sun, B.; Wang, M.; Xu, L.; He, J.; Abliz, Z.; Tan, H.; Li, X.; Yang, H.-B. Smart Stimuli-Responsive Spherical Nanostructures Constructed from Supramolecular Metallodendrimers via Hierarchical Self-Assembly J. Am. Chem. Soc. 2014, 136, 5993-6001 10.1021/ja500152a
155. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles Mol. Pharmaceutics 2008, 5, 505-515 10.1021/mp800051m
156. Narayan, S. P.; Choi, C. H. J.; Hao, L.; Calabrese, C. M.; Auyeung, E.; Zhang, C.; Goor, O. J. G. M.; Mirkin, C. A. The Sequence-Specific Cellular Uptake of Spherical Nucleic Acid Nanoparticle Conjugates. Small 2015, 10.1002/smll.201500027
157. Basuki, J. S.; Jacquemin, A.; Esser, L.; Li, Y.; Boyer, C.; Davis, T. P. A block copolymer-stabilized co-precipitation approach to magnetic iron oxide nanoparticles for potential use as MRI contrast agents Polym. Chem. 2014, 5, 2611-2620 10.1039/c3py01778h
158. Bigall, N. C.; Dilena, E.; Dorfs, D.; Beoutis, M.-L.; Pugliese, G.; Wilhelm, C.; Gazeau, F.; Khan, A. A.; Bittner, A. M.; Garcia, M. A.; Garcia-Hernandez, M.; Manna, L.; Pellegrino, T. Hollow Iron Oxide Nanoparticles in Polymer Nanobeads as MRI Contrast Agents J. Phys. Chem. C 2015, 119, 6246-6253 10.1021/jp508951t
159. Ohno, K.; Mori, C.; Akashi, T.; Yoshida, S.; Tago, Y.; Tsujii, Y.; Tabata, Y. Fabrication of Contrast Agents for Magnetic Resonance Imaging from Polymer-Brush-Afforded Iron Oxide Magnetic Nanoparticles Prepared by Surface-Initiated Living Radical Polymerization Biomacromolecules 2013, 14, 3453-3462 10.1021/bm400770n
160. Hu, S.-H.; Liao, B.-J.; Chiang, C.-S.; Chen, P.-J.; Chen, I. W.; Chen, S.-Y. Core-Shell Nanocapsules Stabilized by Single-Component Polymer and Nanoparticles for Magneto-Chemotherapy/Hyperthermia with Multiple Drugs Adv. Mater. 2012, 24, 3627-3632 10.1002/adma.201201251
161. Hayashi, K.; Maeda, K.; Moriya, M.; Sakamoto, W.; Yogo, T. In situ synthesis of cobalt ferrite nanoparticle/polymer hybrid from a mixed Fe-Co methacrylate for magnetic hyperthermia J. Magn. Magn. Mater. 2012, 324, 3158-3164 10.1016/j.jmmm.2012.05.027
162. Zhang, P.; Yang, J.; Li, W.; Wang, W.; Liu, C.; Griffith, M.; Liu, W. Cationic polymer brush grafted-nanodiamond via atom transfer radical polymerization for enhanced gene delivery and bioimaging J. Mater. Chem. 2011, 21, 7755-7764 10.1039/c1jm10813a
163. Zhang, X.; Zhang, X.; Yang, B.; Liu, M.; Liu, W.; Chen, Y.; Wei, Y. Fabrication of aggregation induced emission dye-based fluorescent organic nanoparticles via emulsion polymerization and their cell imaging applications Polym. Chem. 2014, 5, 399-404 10.1039/C3PY00984J